From: Testing and treatment for malaria elimination: a systematic review
Study | Country | Trans-mission | Species | Design | Total no. clusters | Total population | Test | Drug regimen | Â | Â | Â | Â | Â | Â | Outcome | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RACD as control | RDA Intervention | RDA + RAVC Intervention | Prevalence of infection | Incidence of symptomatic cases | ||||||||||||||||
No. of events | Coverage of events | No. of events | Coverage of events | No. of events | Coverage of events | Follow up (months) | RDA vs RACD PR, 95% CI | RDA + RAVC vs RACD PR, 95% CI | Follow up (months) | RDA vs RACD IRR, 95% CI | RDA + RAVC vs RACD IRR, 95% CI | |||||||||
Ntuku et al. 2020 | Namibia | Low | Pf | CRCT | 56 | 5–20K | RDT | AL | 178 | 84% | 164 | 91% | 144 | 89% | 8 | 0·59 (0·21–0·98) | 0·16 (0·05–0·55) | 12 | 0·52 (0·16–0·88) | 0·26 (0·10–0·68) |
Vilakati et al. 2021 | Eswatini | Very low | Pf | CRCT | 77 | > 50K | RDT | DP | 46 | 70% | 64 | 62% | – | – | – | – | – | 24 | 0.84 (0.42 to 1.66) | – |